SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Nalywayko Maria (Last) (First) (Middle) CORELOGIC, INC. 40 PACIFICA, SUITE 900 (Street) IRVINE CA 90803 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 12/04/2013	3. Issuer Name and Ticker or Trading Symbol CORELOGIC, INC. [ CLGX ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP HR & Strat Project Admin	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	21,883(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(2)	05/31/2020	Common Stock	11,994	$18.76	D
Employee Stock Option (right to buy)	(3)	03/20/2021	Common Stock	6,081	$17.76	D
Employee Stock Option (right to buy)	(4)	03/19/2022	Common Stock	11,304	$16.72	D
Employee Stock Option (right to buy)	(5)	03/19/2023	Common Stock	18,082	$26.13	D

Explanation of Responses:

1. Includes 21,883 unvested Restricted Stock Units (each an "RSU"). Ms. Nalywayko received awards of RSUs on (i) March 20, 2009 and March 22, 2010, each of which is scheduled to vest in five equal annual increments commencing on the first anniversary of the grant date; and (ii) March 21, 2011, March 20, 2012, December 20, 2012 and March 20, 2013, each of which is scheduled to vest in three equal annual increments commencing on the first anniversary of the grant date. Performance-based restricted stock units are not included.

2. The option is scheduled to vest in three equal annual increments which commenced June 1, 2012, the second anniversary of the grant date.

3. The option is scheduled to vest in three equal annual increments which commenced March 21, 2012, the first anniversary of the grant date.

4. The option is scheduled to vest in three equal annual increments which commenced March 20, 2013, the first anniversary of the grant date.

5. The option is scheduled to vest in three equal annual increments commencing March 20, 2014, the first anniversary of the grant date.

	Angela Grinstead, attorney-in-fact for Maria Nalywayko	12/13/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.